Applied DNA, Alphazyme Agreement for Scale-Up Linea™ RNAP

March 18, 2024

Read More

APDN to Showcase Linea™ DNA, Linea™ IVT Platforms at World Vaccine Congress

March 14, 2024

Read More

APDN Announces First Quarter Fiscal Year 2024 Financial Results

February 8, 2024

Read More

APDN to Report FQ1’2024 Financial Results on Thursday, February 8, 2024

February 5, 2024

Read More

APDN Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 31, 2024

Read More

APDN Announces JDA to Integrate Linea™ IVT Platform into Kudo Biotechnology’s mRNA Manufacturing Workflow

December 14, 2023

Read More

APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results

December 7, 2023

Read More

APDN to Report FQ4’23 and Year End Financial Results 12/7/23

December 5, 2023

Read More

APDN Announces Linea™ DNA Follow-On Order for Cancer Diagnostic Application

November 28, 2023

Read More